Predictive Oncology Inc. Announces Receipt of Cash Proceeds of $2.2 Million from Exercise of Warrants

NEXT STORY
CB2 Insights Announces Q1 Financial Statements to be filed on or before July 14, 2020
PREV STORY
Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Algernon to Provide Update on its Ifenprodil IPF and Chronic Cough Phase 2 Human Study Featured on BioPub Webcast Hosted by Dr. KSS MD PhD

author_avatar
NASDAQ Market News

Diasome Announces Substantial Reductions in Level 2 Hypoglycemia Events in its Phase 2b OPTI-1 Study of Hepatocyte Directed Vesicle Technology in Type 1 Diabetes

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the directed share issue without payment to the Company itself

FIT Biotech OyCompany release May 11, 2018 at 2.30 pm EET FIT Biotech Oy's ...

author_avatar
NASDAQ Market News